We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$6.62B
AUM Growth
+$177M
Cap. Flow
-$113M
Cap. Flow %
-1.71%
Top 10 Hldgs %
15.47%
Holding
879
New
57
Increased
333
Reduced
336
Closed
64

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$33.1M
2
AVA icon
Avista
AVA
+$21.5M
3
MGLN
Magellan Health Services, Inc.
MGLN
+$13.7M
4
ABT icon
Abbott
ABT
+$12.8M
5
ALE
Allete
ALE
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.55%
2 Technology 16.34%
3 Financials 14.72%
4 Industrials 10.4%
5 Consumer Discretionary 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USA icon
801
Liberty All-Star Equity Fund
USA
$1.79B
$73K ﹤0.01%
11,381
WIT icon
802
Wipro
WIT
$19B
$72K ﹤0.01%
33,332
MFM
803
Aberdeen Municipal Income Fund
MFM
$221M
$70K ﹤0.01%
10,000
ANIX icon
804
Anixa Biosciences
ANIX
$120M
$64K ﹤0.01%
17,400
COCP icon
805
Cocrystal Pharma
COCP
$12.9M
$40K ﹤0.01%
1,416
+60
+4% +$1.78K
MTVA
806
MetaVia Inc
MTVA
$7.39M
0
LEE icon
807
Lee Enterprises
LEE
$177M
$22K ﹤0.01%
1,000
LCTX icon
808
Lineage Cell Therapeutics
LCTX
$267M
$20K ﹤0.01%
+17,974
New +$20.7K
TNK icon
809
Teekay Tankers
TNK
$2.66B
$18K ﹤0.01%
1,744
ROAN
810
DELISTED
Roan Resources, Inc.
ROAN
$17K ﹤0.01%
+10,000
New +$36.1K
LUMO
811
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$14K ﹤0.01%
1,189
SSI
812
DELISTED
Stage Stores Inc
SSI
$10K ﹤0.01%
13,413
ENVB icon
813
Enveric Biosciences
ENVB
$5.36M
0
NVCN
814
DELISTED
Neovasc Inc.
NVCN
$5K ﹤0.01%
40
OPGN
815
DELISTED
OpGen, Inc
OPGN
$4K ﹤0.01%
+3
New +$5.86K
AGYS icon
816
Agilysys
AGYS
$3.12B
-45,850
Closed -$971K
AME icon
817
Ametek
AME
$55.3B
-4,014
Closed -$333K
BGC icon
818
BGC Group
BGC
$5.73B
-1,910,644
Closed -$10.1M
BXP icon
819
Boston Properties
BXP
$11.2B
-1,959
Closed -$262K
CLB icon
820
Core Laboratories
CLB
$493M
-4,311
Closed -$298K
CLF icon
821
Cleveland-Cliffs
CLF
$6.84B
-830,646
Closed -$8.3M
CM icon
822
Canadian Imperial Bank of Commerce
CM
$109B
-5,258
Closed -$208K
DRI icon
823
Darden Restaurants
DRI
$23.7B
-2,352
Closed -$285K
EGHT icon
824
8x8 Inc
EGHT
$271M
-112,789
Closed -$2.28M
EPP icon
825
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
-5,080
Closed -$233K

Similar funds

Segall Bryant & Hamill's Q2 2019 Portfolio in Review

As of Q2 2019, Segall Bryant & Hamill held 879 positions worth $6.62B, up 2.7% from $6.44B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2019 filing shows 57 new, 333 increased, 336 reduced and 64 closed positions. Its largest new stake was Alcon: 564,559 shares worth $35M. The largest sale was LKQ Corp, an estimated $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Segall Bryant & Hamill's largest Q2 2019 buy was Alcon: 564,559 shares worth $35M.
  • Segall Bryant & Hamill added most to Magellan Health Services, Inc. in Q2 2019, an estimated $13.7M increase.
  • Segall Bryant & Hamill's biggest Q2 2019 reduction was LKQ Corp, cutting an estimated $21.2M.
  • Segall Bryant & Hamill fully exited The GEO Group in Q2 2019, selling an estimated $13.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $6.62B portfolio in Q2 2019.
  • Segall Bryant & Hamill opened 57 new positions and closed 64 in Q2 2019.
  • Segall Bryant & Hamill's portfolio value rose 2.7% quarter-over-quarter to $6.62B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2019, filed 14 Aug 2019.